Sort
48,018 grants matching “immunotherapy”
Fruit exosome-like particles for therapeutic delivery of extracellular miRNAs
$963,705Huang-Ge Zhang · University Of Louisville · UH3 · FY2016 · TR
Targeted Lymphoablation as an alternative to HSCT to cure T1D
$963,581Theresa Deisher · Avm Biotechnology, Llc · R44 · FY2023 · DK
Xenogeneic Stem Cell and Thymic Replacement in AIDS
$963,510Massachusetts General Hospital · P01 · FY2004 · AI
TOLERANCE TO ISLET ALLOGRAFTS IN TYPE I DIABETES
$962,641University Of Minnesota Twin Cities · R01 · FY2003 · DK
Characterization and improvement of graft versus leukemia effects
$962,497Austin J Barrett · National Heart, Lung, And Blood Institute · ZIA · FY2015 · HL
Immunobiology and immunotherapy of leukemia
$962,497Austin J Barrett · National Heart, Lung, And Blood Institute · ZIA · FY2015 · HL
Reprogramming the Tumor-Immune Interface in Oral Cancer
$962,342John B Sunwoo · Stanford University · R35 · FY2025 · DE
Human PSMA MAb Radioimmunotherapy for Prostate Cancer
$962,160Progenics Pharmaceuticals, Inc. · R44 · FY2005 · CA
Novel Targets for Vaccine Therapy
$962,130Claudia Palena · Division Of Basic Sciences - Nci · ZIC · FY2014 · CA
Development
$962,061Ana M Navarro · University Of California, San Diego · U54 · FY2011 · CA
P1 - COMBINATION ACTIVATED T-CELL AND VACCINE THERAPY IN MYELOMA
$961,866Larry W Kwak · University Of Tx Md Anderson Can Ctr · P50 · FY2013 · CA
Combination Immunotherapy of a Novel Superagonist IL-15 Complex and Anti-CD20 Antibody for Indolent Non-Hodgkin Lymphoma
$961,768Hing C. Wong · Altor Bioscience. Llc · R44 · FY2015 · CA
Towards Precision Immuno-Oncology: Unraveling the Genomic Determinants and Mechanisms Underlying Immunotherapy Efficacy and Resistance
$961,680Timothy An-Thy Chan · Cleveland Clinic Lerner Com-Cwru · R35 · FY2024 · CA
Augmem: A Novel Digital Cognitive Assessment for the Early Detection of Alzheimer's Disease
$960,670Adele Gilpin · Augnition Labs Llc · R44 · FY2023 · AG
Tissue Processing-Sequencing Facility
$960,311Cathy D Vocke · Division Of Basic Sciences - Nci · ZIC · FY2024 · CA
Novel Targets for Vaccine Therapy
$960,254Claudia Palena · Division Of Basic Sciences - Nci · ZIC · FY2010 · CA
Vaccine and immunotherapy strategies for cancer and viruses causing cancer
$960,045Jay A Berzofsky · Division Of Clinical Sciences - Nci · ZIA · FY2022 · CA
The Antigen Targeting Core
$959,871Maria Parkhurst · Division Of Basic Sciences - Nci · ZIC · FY2021 · CA
Basis for Success of Multidrug-Resistant Enterobacteriaceae
$959,378Frank Deleo · National Institute Of Allergy And Infectious Diseases · ZIA · FY2021 · AI
Novel Stem Cell Immunotherapy for MDR-Tuberculosis
$959,375Chinnaswamy Jagannath · Methodist Hospital Research Institute · R01 · FY2022 · AI
Novel Stem Cell Immunotherapy for MDR-Tuberculosis
$959,375Chinnaswamy Jagannath · Methodist Hospital Research Institute · R01 · FY2023 · AI
Biomarker Investigations for Clinical Trials
$959,273Liang Cao · Division Of Basic Sciences - Nci · ZIC · FY2019 · CA
P1 - COMBINATION ACTIVATED T-CELL AND VACCINE THERAPY IN MYELOMA
$959,257Larry W Kwak · University Of Tx Md Anderson Can Ctr · P50 · FY2012 · CA
Reprogramming the Tumor-Immune Interface in Oral Cancer
$959,255John B Sunwoo · Stanford University · R35 · FY2024 · DE
ECOG-ACRIN Integrated Leukemia Translational Science Center (LTSC)
$959,146Omar Abdel-Wahab · Sloan-Kettering Inst Can Research · UG1 · FY2019 · CA